Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 48
Filter
1.
Rev. clín. esp. (Ed. impr.) ; 220(2): 109-114, mar. 2020. tab
Article in Spanish | IBECS | ID: ibc-186420

ABSTRACT

Introducción: El síndrome hemofagocítico (SHF) es un trastorno inmunológico grave caracterizado por una inflamación descontrolada con fracaso multiorgánico. Puede estar desencadenado por infecciones víricas, bacterianas, fúngicas o parasitarias. Se describe nuestra experiencia de SHF asociado a infecciones y se estima su incidencia local. Material y método: Estudio retrospectivo observacional de SHF asociado a infecciones en adultos atendidos en el Servicio de Patología Infecciosa de un hospital universitario durante 5años y revisión de las series publicadas en Europa. Resultados: En 2 mujeres con enfermedad de Crohn, el SHF se asoció a infección por citomegalovirus y a leishmaniosis visceral (mieloma múltiple 1, tumor sólido 2, sin enfermedad evidente 1) en 4 pacientes (3 hombres). Fallecieron 2 enfermos. La incidencia estimada fue 0,58/100.000/año. Las series publicadas son heterogéneas. Conclusiones: El SHF asociado a infecciones debe de ser más frecuente de lo descrito. El entorno geográfico puede influir en las infecciones desencadenantes (en nuestro medio, debe buscarse Leishmania)


Background: Haemophagocytic syndrome (HPS) is a severe immunological disorder characterised by uncontrolled inflammation and multiple organ failure. HPS can be triggered by viral, bacterial, fungal and parasitical infections. We report our experience with infection-related HPS and estimate its local incidence. Material and method: We conducted an observational retrospective study of infection-associated HPS in patients treated in the Department of Infectious Diseases of a university hospital within a 5-year period, as well as a review of the published series in Europe. Results: HPS was associated with infection by cytomegalovirus in 2 women with Crohn's disease and was associated with visceral leishmaniosis in 4 patients (3 men, 1 woman; 1 case of multiple myeloma; 2 cases of solid tumours; 1 case of no apparent disease). Two patients died, and the estimated incidence rate was 0.58/100,000 inhabitants/year. The published series are mixed. Conclusions: Infection-related HPS must be more common than reported. The geographical environment can influence the triggering infections (in our environment, Leishmania should be considered)


Subject(s)
Humans , Male , Female , Young Adult , Aged , Lymphohistiocytosis, Hemophagocytic/diagnosis , Multiple Organ Failure/diagnosis , Etoposide/therapeutic use , Glucocorticoids/therapeutic use , Retrospective Studies , Cytomegalovirus Infections/diagnosis , Leishmaniasis/diagnosis , Multiple Myeloma/complications , Crohn Disease/complications , Treatment Outcome
2.
Rev Clin Esp (Barc) ; 220(2): 109-114, 2020 Mar.
Article in English, Spanish | MEDLINE | ID: mdl-31202502

ABSTRACT

BACKGROUND: Haemophagocytic syndrome (HPS) is a severe immunological disorder characterised by uncontrolled inflammation and multiple organ failure. HPS can be triggered by viral, bacterial, fungal and parasitical infections. We report our experience with infection-related HPS and estimate its local incidence. MATERIAL AND METHOD: We conducted an observational retrospective study of infection-associated HPS in patients treated in the Department of Infectious Diseases of a university hospital within a 5-year period, as well as a review of the published series in Europe. RESULTS: HPS was associated with infection by cytomegalovirus in 2 women with Crohn's disease and was associated with visceral leishmaniosis in 4 patients (3 men, 1 woman; 1 case of multiple myeloma; 2 cases of solid tumours; 1 case of no apparent disease). Two patients died, and the estimated incidence rate was 0.58/100,000 inhabitants/year. The published series are mixed. CONCLUSIONS: Infection-related HPS must be more common than reported. The geographical environment can influence the triggering infections (in our environment, Leishmania should be considered).

3.
Open Forum Infect Dis ; 6(6): ofz180, 2019 Jun.
Article in English | MEDLINE | ID: mdl-31198815

ABSTRACT

BACKGROUND: We analyzed the prevalence, etiology, and risk factors of culture-positive preservation fluid and their impact on the management of solid organ transplant recipients. METHODS: From July 2015 to March 2017, 622 episodes of adult solid organ transplants at 7 university hospitals in Spain were prospectively included in the study. RESULTS: The prevalence of culture-positive preservation fluid was 62.5% (389/622). Nevertheless, in only 25.2% (98/389) of the cases were the isolates considered "high risk" for pathogenicity. After applying a multivariate regression analysis, advanced donor age was the main associated factor for having culture-positive preservation fluid for high-risk microorganisms. Preemptive antibiotic therapy was given to 19.8% (77/389) of the cases. The incidence rate of preservation fluid-related infection was 1.3% (5 recipients); none of these patients had received preemptive therapy. Solid organ transplant (SOT) recipients with high-risk culture-positive preservation fluid receiving preemptive antibiotic therapy presented both a lower cumulative incidence of infection and a lower rate of acute rejection and graft loss compared with those who did not have high-risk culture-positive preservation fluid. After adjusting for age, sex, type of transplant, and prior graft rejection, preemptive antibiotic therapy remained a significant protective factor for 90-day infection. CONCLUSIONS: The routine culture of preservation fluid may be considered a tool that provides information about the contamination of the transplanted organ. Preemptive therapy for SOT recipients with high-risk culture-positive preservation fluid may be useful to avoid preservation fluid-related infections and improve the outcomes of infection, graft loss, and graft rejection in transplant patients.

4.
Rev. esp. med. nucl. imagen mol. (Ed. impr.) ; 37(6): 354-358, nov.-dic. 2018. ilus, tab
Article in Spanish | IBECS | ID: ibc-178251

ABSTRACT

Introducción y objetivo: Los síndromes febriles de origen desconocido (SFOD) son procesos complejos en la práctica hospitalaria. Su manejo incluye una anamnesis y exploración clínica exhaustivas, así como una extensa batería de pruebas. Cuando los resultados son inciertos, las técnicas diagnósticas de imagen como la SPECT/TC con galio-67 (67Ga-SPECT/TC) desempeñan un papel importante. Pretendemos evaluar su papel en el estudio de los SFOD en nuestro medio hospitalario. Material y métodos: Hemos revisado 57 pacientes con SFOD a los que se realizó una 67Ga-SPECT/TC (32 mujeres y 25 hombres, rango de edad: 32 a 83 años) recogiendo hallazgos gammagráficos, tratamientos empíricos y diagnóstico final. Se obtuvieron valores de sensibilidad, especificidad, valores predictivos positivos y negativos para la 67Ga-SPECT/TC y se compararon con los resultados descritos en la bibliografía para la PET/TC con Flúor-18-desoxiglucosa (18F-FDG PET/TC). Resultados: Los diagnósticos encontrados fueron: infección en 27/57 (47%), enfermedad inflamatoria en el 15/57 (26%), neoplasia en 1/57 (1,75%) y pacientes sin diagnóstico final en 14/57 (24%). Los valores estadísticos de la 67Ga-SPECT/TC fueron: sensibilidad, especificidad, valor predictivo positivo y negativo de 67%, 93%, 97% y 48%, respectivamente, que fueron levemente inferiores a los encontrados para la 18F-FDG PET/TC (86%, 52%, 70% y 92%, respectivamente). El rendimiento diagnóstico encontrado fue superior en aquellos pacientes que carecían de tratamiento empírico. Conclusión: A pesar los valores superiores del 18F-FDG PET/TC, la 67Ga-SPECT/TC es una técnica útil en el manejo de los SFOD. Es recomendable su uso si el primero no está disponible


Introduction and objective: Febrile syndromes of unknown origin (FSUO) are complex processes in hospital practice. Their management includes an exhaustive medical history and examination, as well as an extensive number of biochemical tests. If these are inconclusive, diagnostic imaging techniques such as SPECT/CT with 67-Gallium Citrate (67Ga-SPECT/CT) could play an important role. We evaluated its role in the management of FSUO in our healthcare area. Material and methods: We reviewed 57 patients who underwent a 67Ga-SPECT/CT due to a FSUO (32 women and 25 men, age range: 32-83 years old) obtaining scintigraphic findings, previous treatments and final diagnosis. Values of sensitivity, specificity, positive predictive values (VPP) and negative values (NPV) were obtained and compared with the results for PET/CT with 18Fluor-deoxy-glucose (18F-FDG PET/CT) found in the literature. Results: The diagnoses found were: infection in 27/57 (47%), inflammatory disease in 15/57 (26%), neoplasm in 1/57 (1.75%) and patients without final diagnosis in 14/57 (24%). The statistical values of 67Ga-SPECT/CT were: sensitivity, specificity, PPV and NPV of 67%, 93%, 97% y 48%, respectively which were slightly lower than those found for the 18F-FDG PET/CT (86%, 52%, 70% and 92%, respectively). The diagnostic yield was 73% which increased to 80% in the patients who lacked empirical treatment. Conclusion: Despite the better results of 18F-FDG PET/CT, 67Ga-SPECT/CT behaved as a useful technique in the management of FSUO. It is advisable to use it if 18F-FDG PET/CT is not available


Subject(s)
Humans , Male , Female , Adult , Middle Aged , Aged , Aged, 80 and over , Gallium Radioisotopes , Single Photon Emission Computed Tomography Computed Tomography/methods , Fever of Unknown Origin/diagnostic imaging , Sensitivity and Specificity , Infections/diagnostic imaging , Inflammation/diagnostic imaging , Neoplasms/diagnostic imaging , Radiotherapy Dosage/standards
5.
Article in English, Spanish | MEDLINE | ID: mdl-30473055

ABSTRACT

INTRODUCTION AND OBJECTIVE: Febrile syndromes of unknown origin (FSUO) are complex processes in hospital practice. Their management includes an exhaustive medical history and examination, as well as an extensive number of biochemical tests. If these are inconclusive, diagnostic imaging techniques such as SPECT/CT with 67-Gallium Citrate (67Ga-SPECT/CT) could play an important role. We evaluated its role in the management of FSUO in our healthcare area. MATERIAL AND METHODS: We reviewed 57 patients who underwent a 67Ga-SPECT/CT due to a FSUO (32 women and 25 men, age range: 32-83 years old) obtaining scintigraphic findings, previous treatments and final diagnosis. Values of sensitivity, specificity, positive predictive values (VPP) and negative values (NPV) were obtained and compared with the results for PET/CT with 18Fluor-deoxy-glucose (18F-FDG PET/CT) found in the literature. RESULTS: The diagnoses found were: infection in 27/57 (47%), inflammatory disease in 15/57 (26%), neoplasm in 1/57 (1.75%) and patients without final diagnosis in 14/57 (24%). The statistical values of 67Ga-SPECT/CT were: sensitivity, specificity, PPV and NPV of 67%, 93%, 97% y 48%, respectively which were slightly lower than those found for the 18F-FDG PET/CT (86%, 52%, 70% and 92%, respectively). The diagnostic yield was 73% which increased to 80% in the patients who lacked empirical treatment. CONCLUSION: Despite the better results of 18F-FDG PET/CT, 67Ga-SPECT/CT behaved as a useful technique in the management of FSUO. It is advisable to use it if 18F-FDG PET/CT is not available.


Subject(s)
Fever of Unknown Origin/diagnostic imaging , Gallium Radioisotopes , Positron Emission Tomography Computed Tomography , Adult , Aged , Aged, 80 and over , Female , Fever of Unknown Origin/etiology , Humans , Male , Middle Aged , Retrospective Studies , Syndrome
6.
HIV Med ; 18(3): 196-203, 2017 03.
Article in English | MEDLINE | ID: mdl-27476742

ABSTRACT

OBJECTIVES: The aim of the study was to investigate whether very low level viraemia (VLLV) (20-50 HIV-1 RNA copies/mL) was associated with increased risk of virological failure (VF) as compared with persistent full suppression (< 20 copies/mL). METHODS: From the VACH Cohort database, we selected those patients who started antiretroviral therapy (ART) after January 1997 and who achieved effective viral suppression [two consecutive viral loads (VLs) < 50 copies/mL] followed by full suppression (at least one VL <20 copies/mL). We carried out survival analyses to investigate whether the occurrence of VLLV rather than maintaining full suppression at < 20 copies/mL was associated with virological failure (two consecutive VLs > 200 copies/mL or one VL > 200 copies/mL followed by a change of ART regimen, administrative censoring or loss to follow-up), adjusted for nadir CD4 cell count, sex, age, ethnicity, transmission group, type of ART and time on effective suppression at < 50 copies/mL. RESULTS: Of 21 480 patients who started ART, 13 674 (63.7%) achieved effective suppression at < 50 copies/mL, of whom 4289 (31.4%) further achieved full suppression at < 20 copies/mL after May 2009. A total of 2623 patients (61.1%) remained fully suppressed thereafter, while 1666 had one or more episodes of VL detection > 20 copies/mL (excluding virological failure). A total of 824 patients had VLLV after suppression at < 20 copies/mL. VLLV was not associated with virological failure as compared with persistent full suppression [hazard ratio (HR) 0.67; 95% confidence interval (CI) 0.44-1.00], independently of the number of blips recorded (from one to 18). CONCLUSIONS: In our population of HIV-infected patients on ART who achieved viral suppression at < 20 copies/mL, the risk of virological failure was no different for patients who remained fully suppressed compared with those who experienced subsequent episodes of VLLV.


Subject(s)
Anti-Retroviral Agents/therapeutic use , HIV Infections/drug therapy , HIV-1/isolation & purification , Sustained Virologic Response , Viral Load , Viremia , Adolescent , Adult , Cohort Studies , Female , HIV Infections/virology , Humans , Incidence , Male , Middle Aged , Risk , Risk Assessment , Treatment Failure , Young Adult
7.
Transplant Proc ; 48(9): 2931-2937, 2016 Nov.
Article in English | MEDLINE | ID: mdl-27932110

ABSTRACT

BACKGROUND: Kidney transplant patients with D+/R+ serology can be treated with either prophylaxis or preemptive valganciclovir. The older transplant population suffers severe immunosenescence, especially patients with latent cytomegalovirus (CMV) infection (R+). They are more likely to develop indirect CMV effects. Likewise, many patients have significant cardiovascular comorbidity, which makes them more sensitive to these indirect effects. The aim of this study was to evaluate the incidence of CMV viremia and indirect effects on survival, comparing prophylaxis (V) against preemptive (P) valganciclovir in an older kidney transplant population. METHODS: We analyzed the data of 233 recipients from 2002 (age, >55 years; D+/R+) with ≥6 months of follow-up. The patients were divided into 2 groups: 167 (71.7%) in the V group and 66 (28.3%) in the P group. RESULTS: The incidence of CMV infection in the P group was 32% versus 6% in V group. Patients with CMV viremia showed worse survival values than patients without viremia (log rank P = .031). Five-year survivals were 74% vs 88%, respectively. Cox regression showed that the adjusted effect of CMV infection on overall survival was a significant risk (hazard ratio [HR], 2.07; 95% CI, 1.003-4.29). Patients with CMV viremia showed worse cardiovascular survival than patients without viremia, with 5-year survivals of 79% vs 94%. Cox regression showed that the adjusted effect of CMV infection was a significant risk (HR, 2.62). CONCLUSIONS: CMV infection has a detrimental effect on the survival of older patients. Valganciclovir prophylaxis induces a protective effect against CMV infection and could improve survival of older patients with cardiovascular comorbidities.


Subject(s)
Antiviral Agents/therapeutic use , Cytomegalovirus Infections/prevention & control , Ganciclovir/analogs & derivatives , Cytomegalovirus/immunology , Cytomegalovirus Infections/mortality , Epidemiologic Methods , Female , Ganciclovir/therapeutic use , Humans , Kidney Transplantation/adverse effects , Kidney Transplantation/mortality , Male , Middle Aged , Recurrence , Time Factors , Valganciclovir , Viremia/etiology , Viremia/mortality , Viremia/prevention & control
8.
Rev. clín. esp. (Ed. impr.) ; 214(5): 247-252, jun.-jul. 2014.
Article in Spanish | IBECS | ID: ibc-122770

ABSTRACT

Introducción: La leptospirosis tiene una distribución mundial y predomina en regiones tropicales. Su incidencia puede estar infraestimada. Describimos las características de la leptospirosis en el suroeste de España. Pacientes y métodos: Serie de casos retrospectiva de 86 casos de leptospirosis diagnosticados entre abril de 1997 y abril de 2013. Se analizan datos epidemiológicos, clínicos, analíticos y pronósticos. Resultados. La edad media de los pacientes fue de 43,1 años (desviación estándar 13,8). El 84,9% fueron varones. La incidencia anual media fue de 1,99/100.000 habitantes. El 94% de los pacientes tenían actividades de riesgo: contacto con animales en el 82,5% y con aguas estancadas en el 31,7%. Las principales manifestaciones clínicas fueron la fiebre (94,1%), artromialgias (60,7%) y cefalea (53,3%). El 48% de los casos tuvieron hipertransaminemia, el 26,3% insuficiencia renal y el 16,9% trombocitopenia. Trece pacientes (15,1%) tuvieron enfermedad de Weil (EW) y 11 meningitis. Los pacientes con meningitis eran de menor edad (31,2±9,2 frente a 44,8±15,2, p=0,004) y los pacientes con EW de mayor edad (53,5±15,8 frente a 41,2±14,5, p=0,007). Cincuenta y siete pacientes requirieron hospitalización (66,3%) y 6 de ellos fallecieron (7,0%). Se asociaron a mortalidad la edad superior a los 60 años (odds ratio [OR] 45,0, intervalo de confianza al 95% [IC 95%] 4,7-436,6) y el diagnóstico de EW (OR 15,8, IC 95% 2,5-98,7). Conclusiones: La leptospirosis tiene en nuestro entorno una incidencia no despreciable. Incide preferentemente en varones con actividades reconocidas como de riesgo, que presentan fiebre y artromialgias. Debe incluirse en el diagnóstico diferencial de la meningitis linfocitaria. La mortalidad se asocia a mayor edad (AU)


Introduction: Leptospirosis is a zoonosis of worldwide distribution and tropical predominance. Its incidence could be underestimated in template regions. We describe the manifestations of leptospirosis in an area of Southwestern Spain. Patients and methods: Eighty-six cases of leptospirosis (April 1997-April 2013) were retrospectively analyzed. The diagnosis was based in clinical and serological (Leptospira IgM ELISA) judgement. Epidemiological, clinical, laboratory, and prognostic dates were recorded. Results: The mean age was 43.1±13.8 years (84.9% males). The mean annual incidence was 1.99/100.000. There were activities of risk in 94%: 82.5% contact with animals (57.4% pigs, 38.1% dogs, 31.7% cows, 22.2% sheeps), and 31.7% contact with pooled water. The most frequent symptoms were fever (94.1%), arthromyalgias (60.7%), and cephalalgia (53.3%). The main laboratory alterations were hypertransaminemia (48%), renal insufficiency (26.3%), and thrombocytopenia (16.9%). A lymphocytic meningitis was associated in 11 cases (12.5%) and a picture of Weil's disease was observed in 13 patients (15.1%). The patients with meningitis were younger (31.2±9.2 versus 44.8 ±15.2, p=0.004). The patients with Weil's disease were older (53.5±15.8 versus 41.2±14.5, p=0.007). Fifty seven patients were hospitalized (66.3%) and 6 patients died (7.0%). Factors independently associated with mortality were age >60 years (odds ratio [OR] 45.0, confidence interval 95% [CI95%] 4.7-434.6) and diagnosis of Weil's disease (OR 15.8, CI95% 2.5-98.7). Conclusions: In our experience, leptospirosis have a not despicable incidence and tends to show fever and arthromyalgias in men with risk activities. Leptospirosis should be included in the differential diagnosis of lymphocytic meningitis. Mortality is associated with older age (AU)


Subject(s)
Humans , Leptospira/pathogenicity , Leptospirosis/epidemiology , Arthralgia/etiology , Diagnosis, Differential , Risk Factors , Primary Health Care , Zoonoses/transmission , Retrospective Studies
9.
Rev Clin Esp (Barc) ; 214(5): 247-52, 2014.
Article in English, Spanish | MEDLINE | ID: mdl-24703813

ABSTRACT

INTRODUCTION: Leptospirosis is a zoonosis of worldwide distribution and tropical predominance. Its incidence could be underestimated in template regions. We describe the manifestations of leptospirosis in an area of Southwestern Spain. PATIENTS AND METHODS: Eighty-six cases of leptospirosis (April 1997-April 2013) were retrospectively analyzed. The diagnosis was based in clinical and serological (Leptospira IgM ELISA) judgement. Epidemiological, clinical, laboratory, and prognostic dates were recorded. RESULTS: The mean age was 43.1 ± 13.8 years (84.9% males). The mean annual incidence was 1.99/100.000. There were activities of risk in 94%: 82.5% contact with animals (57.4% pigs, 38.1% dogs, 31.7% cows, 22.2% sheeps), and 31.7% contact with pooled water. The most frequent symptoms were fever (94.1%), arthromyalgias (60.7%), and cephalalgia (53.3%). The main laboratory alterations were hypertransaminemia (48%), renal insufficiency (26.3%), and thrombocytopenia (16.9%). A lymphocytic meningitis was associated in 11 cases (12.5%) and a picture of Weil's disease was observed in 13 patients (15.1%). The patients with meningitis were younger (31.2 ± 9.2 versus 44.8 ± 15.2, p=0.004). The patients with Weil's disease were older (53.5 ± 15.8 versus 41.2 ± 14.5, p=0.007). Fifty seven patients were hospitalized (66.3%) and 6 patients died (7.0%). Factors independently associated with mortality were age >60 years (odds ratio [OR] 45.0, confidence interval 95% [CI95%] 4.7-434.6) and diagnosis of Weil's disease (OR 15.8, CI95% 2.5-98.7). CONCLUSIONS: In our experience, leptospirosis have a not despicable incidence and tends to show fever and arthromyalgias in men with risk activities. Leptospirosis should be included in the differential diagnosis of lymphocytic meningitis. Mortality is associated with older age.


Subject(s)
Leptospirosis/epidemiology , Weil Disease/epidemiology , Zoonoses/epidemiology , Adult , Age Factors , Aged , Animals , Cattle , Diagnosis, Differential , Dogs , Enzyme-Linked Immunosorbent Assay , Female , Humans , Incidence , Leptospirosis/mortality , Male , Middle Aged , Retrospective Studies , Risk Factors , Sheep , Spain/epidemiology , Swine , Young Adult , Zoonoses/microbiology , Zoonoses/mortality
10.
Rev. clín. esp. (Ed. impr.) ; 211(5): 247-250, mayo 2011.
Article in Spanish | IBECS | ID: ibc-131394

ABSTRACT

Un varón de 53 años de edad ingresado por rachas de taquicardia ventricular sostenida y sometido a cardioversión eléctrica, portador de una vía venosa central femoral derecha, comienza con picos febriles, y en los hemocultivos se aísla Staphylococcus epidermidis. ¿Qué valor tiene el aislamiento, en los hemocultivos, de S. epidermidis, un microorganismo que forma parte de la flora habitual de la piel y mucosas del paciente? ¿Cómo debe manejarse esta situación? ¿Deben administrarse antimicrobianos? ¿Cuáles? ¿Durante cuánto tiempo?(AU)


A 53-year old male admitted for episodes of sustained ventricular tachycardia subjected to electrical cardioversion, carrier of a right femoral central venous catheter, began with febrile peaks, and Staphylococcus epidermidis was isolated in the blood cultures. What is the value of isolation in the blood cultures of S. epidermidis, a microorganism that forms a part of the usual flora of the skin and mucous of the patient? How should this situation be managed? Should an antimicrobial agent be administered? Which one? For how long?(AU)


Subject(s)
Humans , Male , Middle Aged , 24966/methods , Fever/complications , Fever/etiology , Staphylococcus epidermidis/isolation & purification , Staphylococcus epidermidis/metabolism , Staphylococcus epidermidis/pathogenicity , Bacteremia/complications , Bacteremia/diagnosis , Catheter Ablation/methods , Microbial Sensitivity Tests , Microbiology/trends , 24966/policies , Microbiological Techniques , Electric Countershock , Staphylococcus epidermidis , Bacteremia/microbiology , Leukocytosis/complications
11.
Rev Clin Esp ; 211(5): 247-50, 2011 May.
Article in Spanish | MEDLINE | ID: mdl-21466882

ABSTRACT

A 53-year old male admitted for episodes of sustained ventricular tachycardia subjected to electrical cardioversion, carrier of a right femoral central venous catheter, began with febrile peaks, and Staphylococcus epidermidis was isolated in the blood cultures. What is the value of isolation in the blood cultures of S. epidermidis, a microorganism that forms a part of the usual flora of the skin and mucous of the patient? How should this situation be managed? Should an antimicrobial agent be administered? Which one? For how long?


Subject(s)
Bacteremia/blood , Bacteremia/microbiology , Staphylococcus epidermidis/isolation & purification , Coagulase , Humans , Male , Middle Aged , Staphylococcus epidermidis/enzymology
12.
HIV Med ; 10(9): 573-9, 2009 Oct.
Article in English | MEDLINE | ID: mdl-19785666

ABSTRACT

BACKGROUND: Reports have shown that the publication of practice guidelines does not guarantee their use in clinical practice. The objective of this study was to evaluate the agreement between antiretroviral treatments (ARTs) prescribed in clinical practice and the recommendations in published guidelines. METHODS: A retrospective cohort study was carried out in ART-naïve adults of the Spanish Asociacion Medica Vach de Estudios Multicentricos (VACH) Cohort for the period from 2003 to 2006. RESULTS: A total of 945 patients initiated ART. Of these patients, 12.3% had a CD4 cell count above 350 cells/microL. A 'nonrecommended' antiretroviral regimen was prescribed to 5.3, 5.1 and 7.8% of patients with CD4 counts <200, 200-350 and >350 cells/microL, respectively. Multivariate analyses demonstrated that only a higher viral load was associated with the selection of a combination treatment that was recommended by the guidelines. CONCLUSIONS: Most patients were prescribed initial treatments in agreement with the recommendations. Appropriate routine data collection in databases can be used to evaluate the level of antiretroviral guideline compliance. We propose that routine evaluations of the guidelines must be part of quality assessment to improve medical care.


Subject(s)
Anti-Retroviral Agents/therapeutic use , Guideline Adherence/standards , HIV Infections/drug therapy , HIV-1 , Practice Guidelines as Topic/standards , Practice Patterns, Physicians' , Adult , Aged , CD4 Lymphocyte Count , Female , HIV Infections/immunology , Humans , Male , Middle Aged , Multivariate Analysis , Retrospective Studies , Spain , Time Factors , Viral Load
19.
Enferm Infecc Microbiol Clin ; 17(4): 176-9, 1999 Apr.
Article in Spanish | MEDLINE | ID: mdl-10365511

ABSTRACT

BACKGROUND: Mumps is a viral infection which is particularly found in children and adolescents and one of its manifestations is as lymphocytary meningitis. The aim of this study was to analyze the clinical, epidemiologic and serologic characteristics of the cases of meningitis by the mumps virus (MMV) observed during an epidemic of mumps. SUBJECTS AND METHODS: Twenty-eight cases of MMV diagnosed from December 1, 1994 to August 31, 1995 during an epidemic of mumps in the south of the province of Badajoz (Spain) were analyzed. Demographic, clinical, analytical and evolutive data were obtained. RESULTS: Cases predominated in the winter and summer in adolescents and youths (mean age 16.9 years) with a male:female relationship of 3:1. On admission most patients presented fever, headache, and parotid hypertrophy. Orchitis was observed in half of the males. No case of encephalitis was seen. Hyperproteinorrhachia was observed in the cephalorrhachidian fluid of 79% of the cases and hypoglucorrhachia was found in only two patients (7%). The course was benign, except in four patients (14%) who had sequelae (headache, unilateral hyperacusia and testicular discomfort). CONCLUSIONS: The epidemiologic and liquoral data of MMV in adolescents agree with those described in series of children. Nonetheless, the absence of encephalic involvement and the high proportion of orchitis is of note.


Subject(s)
Meningitis, Viral/epidemiology , Mumps/epidemiology , Adolescent , Adult , Child , Disease Outbreaks , Female , Humans , Male , Meningitis, Viral/diagnosis , Meningitis, Viral/physiopathology , Mumps/diagnosis , Mumps/physiopathology , Mumps virus/isolation & purification , Spain/epidemiology
20.
Enferm Infecc Microbiol Clin ; 16 Suppl 1: 52-60, 1998.
Article in Spanish | MEDLINE | ID: mdl-9859620

ABSTRACT

Intestinal parasite infections are very frequent in HIV patients with severe immunodeficiency (CD4 < 100/mm3) causing chronic diarrhea and malabsorption in the majority of cases. The most frequent microorganisms are microsporidia and Cryptosporidium parvum while Cyclospora cayetanensis and Isospora belli are more prevalent in subtropical and tropical areas and rare in industrialized areas. The diagnosis can be obtained by stool examination (differences in size and form of cysts), although microsporidia is frequently demonstrated by intestinal biopsy and/or duodenal aspirate. The treatment with cotrimoxazole for C. cayetanensis and I. belli is very effective and does not present any problems in the acute phase, however, due to a high percentage of relapses the treatment must be maintained while the patient is in a severe immunodeficiency state. E. intestinalis usually responds satisfactorily to albendazole while E. bieneusi is resistant to some drugs except in some cases (albendazole, atovaquone ad fumagillin). C parvum is also resistant to most medicaments but shows an adequate or partial clinical: response to paramomicine (< 50%). When there is no response, it is advised to administer octreotide since in half the cases the response is positive either total or partial. Nowadays with the use of protease inhibitors in the antiretroviral treatment a decrease in the incidence of these infections has been observed (microsporidia and C. parvum) even in the stools samples taken from the patients who had them before. As primary prophylaxis for C. parvum, it is better to avoid been exposed to the microorganism taking into account the 1997 preventive measures recommended by the USPHS/IDSA Prevention of Opportunistic Infections Working Group. The coinfection Leishmania-HIV is frequent in the mediterranean area. The most common specie is L. infantum. The incidence is most frequent in immunosuppressed patients (CD4 < 200 mm3) and in parenteral drug addicts. The symptomatology is similar to the one from immunocompetent patients, although in some cases it appears to be subclinical. A chronic development with relapses is frequent. The most effective diagnostic method for the finding of the parasites is thru bone marrow puncture and the culture in Novy-McNeal-Nicolle (NNN) medium. Serological tests have a low sensibility and the PCR is useful in asymptomatic cases, for therapeutical control and in relapses. The treatment is similar to that of immunocompetent patients, using primarily antimonials or amphotericine B (standard or lipid or liposomal forms). Relapses are very frequent, therefore, it is important to perform a secondary prophylaxis. However, no treatment has been completely effective. Mortality rate is high (approximately 25%) during the first month after diagnosis. This fact may be related to the severe immunodeficiency state and/or to the toxicity of the drugs used. The main priority for the future is to find a first line treatment with higher efficacy, decrease in relapses and a lower toxicity.


Subject(s)
AIDS-Related Opportunistic Infections , Intestinal Diseases, Parasitic , Leishmaniasis , AIDS-Related Opportunistic Infections/diagnosis , AIDS-Related Opportunistic Infections/drug therapy , AIDS-Related Opportunistic Infections/epidemiology , AIDS-Related Opportunistic Infections/prevention & control , Animals , Anti-HIV Agents/pharmacology , Antiprotozoal Agents/pharmacology , Antiprotozoal Agents/therapeutic use , Cryptosporidiosis/diagnosis , Cryptosporidiosis/drug therapy , Cryptosporidiosis/epidemiology , Cryptosporidiosis/prevention & control , Drug Interactions , Humans , Incidence , Intestinal Diseases, Parasitic/diagnosis , Intestinal Diseases, Parasitic/drug therapy , Intestinal Diseases, Parasitic/epidemiology , Intestinal Diseases, Parasitic/prevention & control , Leishmania infantum , Leishmaniasis/diagnosis , Leishmaniasis/drug therapy , Leishmaniasis/epidemiology , Leishmaniasis/prevention & control , Leishmaniasis, Visceral/diagnosis , Leishmaniasis, Visceral/drug therapy , Leishmaniasis, Visceral/epidemiology , Leishmaniasis, Visceral/prevention & control , Treatment Failure
SELECTION OF CITATIONS
SEARCH DETAIL
...